EcoR1 Capital Discloses 13.22% Stake in Galapagos NV – $399M Invested
EcoR1 Capital files Amendment No. 3 to Schedule 13D on Galapagos NV (GLPG).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EcoR1 Capital files Amendment No. 3 to Schedule 13D on Galapagos NV (GLPG). The biotech-focused hedge fund and its founder Oleg Nodelman now report beneficial ownership of 8,714,522 ordinary shares/ADSs, equal to 13.22 % of the 65,897,071 shares outstanding (Form 20-F, 31 Dec 2024). The position is concentrated in EcoR1 Capital Fund Qualified, L.P. (8.19 m shares, 12.43 %) while EcoR1 Capital Fund, L.P. holds 0.52 m shares (0.79 %).
The shares were accumulated for an aggregate US$399.4 million; an additional US$293,693 in fees was paid to Citibank for converting ADSs into ordinary shares. EcoR1 and Mr Nodelman have shared voting and dispositive power over the entire stake.
Apart from updating share totals and cost, the filing makes no changes to the previously stated purpose of the investment or to any contracts, arrangements or relationships with the issuer. Exhibit 99.2 details trades executed in the past 60 days; no other transactions were disclosed.
Positive
- EcoR1 Capital’s 13.22 % stake demonstrates significant institutional confidence in GLPG.
- US$399.4 million invested underscores long-term commitment from a biotech-focused fund.
Negative
- None.
Insights
TL;DR: EcoR1 now controls 13.22 % of GLPG after spending US$399 m; no new activist intentions disclosed.
Impact: The disclosure confirms a sizeable, above-13 % holding by a specialist biotech investor, signalling continued conviction in Galapagos. The amendment mainly reflects share tally updates and ADS conversion fees, with voting power remaining shared among EcoR1 entities and founder Oleg Nodelman. Absence of purpose changes means investors gain transparency on stake size but no fresh strategic clues. Overall, the filing is noteworthy for ownership concentration yet neutral regarding immediate operational or financial effects.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much has EcoR1 spent acquiring its GLPG position?
Does the filing change EcoR1’s stated purpose for investing in Galapagos?
AI-generated analysis. How Rhea-AI works. Not financial advice.